Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

June 14, 2025

Study Completion Date

July 14, 2025

Conditions
Abortion, Second TrimesterPPROMRupture, SpontaneousFetal DemiseFetal DeathFetal Demise From MiscarriageFetal Death Before 22 Weeks With Retention of Dead FetusPregnancy LossPregnancy Complications
Interventions
DRUG

Mifepristone

200mg orally

DRUG

Misoprostol

Per clinician

Trial Locations (1)

63110

Barnes-Jewish Hospital, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER